G. Gersuk

发表

Methods of in vitro macrophage maturation confer variable inflammatory responses in association with altered expression of cell surface dectin-1.

K. Marr, G. Gersuk, L. Razai, 2008, Journal of immunological methods.

Dectin-1 and TLRs Permit Macrophages to Distinguish between Different Aspergillus fumigatus Cellular States1

D. Underhill, K. Marr, G. Gersuk, 2006, The Journal of Immunology.

T-lymphocyte clones from leprosy skin lesions.

B. Bloom, R. Modlin, T. Rea, 1986, Leprosy review.

urine from patients with myeloproliferative disorders Platelet-derived growth factor concentrations in platelet-poor plasma and

R. Carmel, G. Gersuk, P. Pattengale, 2011 .

Platelet-derived growth factor concentrations in platelet-poor plasma and urine from patients with myeloproliferative disorders.

R. Carmel, P. Pattengale, G. Gersuk, 1989, Blood.

Platelet-derived growth factor concentrations in platelet-poor plasma and urine from patients with myeloproliferative disorders.

R. Carmel, G. Gersuk, P. Pattengale, 1989, Blood.

Inhibition of Human Natural Killer Cell Activity by Platelet‐Derived Growth Factor (PDGF)

B. Westermark, P. Challita, G. Gersuk, 1991, Scandinavian journal of immunology.

Human monocytes differentiate into macrophages under the influence of human KPB-M15 conditioned medium.

K. Marr, G. Gersuk, A. Hiraoka, 2005, Journal of immunological methods.

A role for tumour necrosis factor‐α, Fas and Fas‐Ligand in marrow failure associated with myelodysplastic syndrome

P. Kiener, M. Loken, J. Ledbetter, 1998, British journal of haematology.

Fas (CD95) receptor and Fas-ligand expression in bone marrow cells from patients with myelodysplastic syndrome.

H. Deeg, J. Anderson, G. Gersuk, 1996, Blood.

Inhibition of human natural killer cell activity by platelet-derived growth factor.

G. Gersuk, W. Chang, P. Pattengale, 1986, Natural immunity and cell growth regulation.

Recognition of major histocompatibility complex class II antigens by two anti-HLA-DR monoclonal antibodies on canine marrow cells correlates with effects on in vitro and in vivo hematopoiesis.

H. Deeg, M. Yamaguchi, P. Mcsweeney, 1999, Transplantation.

MyD88 Signaling Contributes to Early Pulmonary Responses to Aspergillus fumigatus

R. Hackman, J. Staab, K. Marr, 2007, Infection and Immunity.

Inhibition of human natural killer cell activity by platelet-derived growth factor. II. Membrane binding studies, effects of recombinant IFN-alpha and IL-2, and lack of effect on T cell and antibody-dependent cellular cytotoxicity.

G. Gersuk, W. Chang, P. Pattengale, 1988, Journal of immunology.

HLA-DR-triggered inhibition of hemopoiesis involves Fas/Fas ligand interactions and is prevented by c-kit ligand.

H. Deeg, P. Kiener, J. Ledbetter, 1997, Journal of immunology.

Hla-dr-initiated inhibition of hematopoiesis involves apoptosis via a fas/fas-ligand pathway

H. Deeg, P. Kiener, G. Gersuk, 1996 .

Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicity.

R. Carmel, A. Rabinowitz, P. Challita, 1993, Natural immunity.

Correlation between allergy and persistent Epstein-Barr virus infections in chronic-active Epstein-Barr virus-infected patients.

G. B. Olson, L. Kelley, G. Gersuk, 1986, The Journal of allergy and clinical immunology.